Home » MultiCell Technologies Granted European Patent for the Treatment of Cancer
MultiCell Technologies Granted European Patent for the Treatment of Cancer
MultiCell Technologies, Inc. announced Monday that it has been granted a European patent (EP 1539819B1) covering certain of its therapeutic candidates for the treatment of cancer.
CNBC
CNBC
Upcoming Events
-
07May
-
14May
-
30May